Raphael Pharmaceutical (RAPH) Payables (2020 - 2025)

Raphael Pharmaceutical has disclosed Payables across 6 years of filings, most recently posting $540000.0 for Q4 2025.

• Payables for Q4 2025 came in at $540000.0, down 25.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $540000.0 (down 25.82% YoY), and the FY2025 annual result was $540000.0, down 25.82% from the prior year.
• Payables came in at $540000.0 for Q4 2025 at Raphael Pharmaceutical, down from $1.2 million in the prior quarter.
• In the past five years, Payables ranged from a high of $1.2 million in Q3 2025 to a low of $64000.0 in Q2 2022.
• The 5-year median for Payables is $345000.0 (2021), against an average of $375277.8.
• Across the five-year window, Payables tumbled 72.43% in 2022 and soared 451.52% in 2024, its largest moves.
• Raphael Pharmaceutical's Payables stood at $272000.0 in 2021, then sank by 72.43% to $75000.0 in 2022, then jumped by 76.0% to $132000.0 in 2023, then jumped by 451.52% to $728000.0 in 2024, then retreated by 25.82% to $540000.0 in 2025.
• The last three Payables figures came in at $540000.0 (Q4 2025), $1.2 million (Q3 2025), and $514000.0 (Q2 2025), per Business Quant data.